About this trial

Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients.

Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.

Eligibility criteria

Qualifiers

ischemic/hemmorhagic stroke

written consent form

Disqualifiers

pre-existing dementia or cognitive impairment before stroke onset

pre-existing mental disorder (depression) or present/prior long-term treatment (> 6 months) with psychotropic drugs

pre-existing malign tumor disease

participation in another clinical trial within the past 30 days

Trial design

Treatments tested in this trial

  • Kölner Neuropsychologische Screening für Schlaganfall-Patienten

Treatment groups

80 Participants
are divided into 1 treatment group

Locations

1
Institute for Neurorehabilitation Research, BDH-Clinic Hessich Oldendorf31840, Hessisch OldendorfLower Saxony, Germany

Sponsors and collaborators

BDH-Klinik Hessisch Oldendorf

Lead sponsor